Get the Stockscreener App
96.42
0.94%
0.90
Pre-market:
96.42
Boston Scientific Corp stock is traded at $96.42, with a volume of 8.69M.
It is up +0.94% in the last 24 hours and down -8.84% over the past month.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
See More
Previous Close:
$95.52
Open:
$98.04
24h Volume:
8.69M
Relative Volume:
1.44
Market Cap:
$142.29B
Revenue:
$16.75B
Net Income/Loss:
$1.85B
P/E Ratio:
77.14
EPS:
1.25
Net Cash Flow:
$2.37B
1W Performance:
-7.92%
1M Performance:
-8.84%
6M Performance:
+15.02%
1Y Performance:
+42.87%
1-Day Range:
$96.01
$98.56
1-Week Range:
$93.29
$103.51
52-Week Range:
$65.52
$107.17
Boston Scientific Corp Stock (BSX) Company Profile
Name
Boston Scientific Corp
Sector
Industry
Phone
508-683-4000
Address
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Compare BSX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
96.42 | 142.29B | 16.75B | 1.85B | 2.37B | 1.25 |
|
ABT
Abbott Laboratories
|
130.28 | 225.95B | 41.95B | 13.40B | 6.35B | 7.65 |
|
SYK
Stryker Corp
|
363.84 | 138.83B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
91.51 | 117.34B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
68.51 | 40.28B | 5.72B | 4.17B | 259.90M | 6.97 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-10-25 | Upgrade | Deutsche Bank | Hold → Buy |
| Oct-18-24 | Downgrade | Needham | Buy → Hold |
| May-30-24 | Initiated | Goldman | Buy |
| Feb-01-24 | Upgrade | Mizuho | Neutral → Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Jun-30-23 | Initiated | CL King | Buy |
| May-30-23 | Resumed | Morgan Stanley | Overweight |
| Mar-29-23 | Initiated | UBS | Buy |
| Dec-22-22 | Initiated | Mizuho | Neutral |
| Dec-20-22 | Resumed | Citigroup | Buy |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-06-22 | Initiated | Wolfe Research | Outperform |
| May-27-22 | Upgrade | Needham | Hold → Buy |
| Apr-13-22 | Resumed | Truist | Buy |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| May-26-21 | Downgrade | Needham | Buy → Hold |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-15-21 | Initiated | Atlantic Equities | Overweight |
| Sep-17-20 | Initiated | Truist | Buy |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| Apr-22-20 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-01-20 | Upgrade | Goldman | Neutral → Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Neutral |
| Feb-06-20 | Resumed | BTIG Research | Buy |
| Dec-30-19 | Reiterated | Cowen | Outperform |
| Dec-19-19 | Downgrade | Needham | Strong Buy → Buy |
| Sep-05-19 | Resumed | JP Morgan | Overweight |
| Sep-03-19 | Resumed | Barclays | Overweight |
| May-13-19 | Upgrade | Evercore ISI | In-line → Outperform |
| Nov-28-18 | Initiated | UBS | Buy |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Oct-02-18 | Reiterated | Morgan Stanley | Overweight |
| Sep-07-18 | Reiterated | Needham | Strong Buy |
| Sep-04-18 | Upgrade | Jefferies | Hold → Buy |
| Jul-06-18 | Reiterated | Needham | Strong Buy |
| Jun-27-18 | Initiated | Bernstein | Outperform |
| Apr-26-18 | Reiterated | Needham | Strong Buy |
View All
Boston Scientific Corp Stock (BSX) Latest News
Boston Scientific’s SWOT analysis: medtech giant’s stock poised for growth - Investing.com
Neurosurgery Market Size to Reach USD 6.8 Billion by 2034, Growing at 4.5% CAGR with Technological Advancements and Rising Focus on Personalized Medicine – Analysis by TMR - GlobeNewswire Inc.
Boston Scientific (BSX) Gains As Market Dips: What You Should Know - Yahoo Finance
Boston Scientific (NYSE:BSX) Sees 4% Price Rise Following Strong Earnings Report - Yahoo Finance
Boston Scientific Gains 42.2% in a Year: What's Driving the Stock? - Yahoo Finance
Boston Scientific price target raised to $110 from $100 at Bernstein - MSN
Estimating The Fair Value Of Boston Scientific Corporation (NYSE:BSX) - Yahoo Finance
4C raises $175M for mitral valve technology - BioWorld Online
Boston Scientific Corp. stock underperforms Thursday when compared to competitors - MarketWatch
How Boston Scientific (sort of) became ‘Minnesota Scientific’ - Star Tribune
Boston Scientific at TD Cowen Conference: Strategic Growth Insights - Investing.com
Boston Scientific (BSX) Gains But Lags Market: What You Should Know - Yahoo Finance
Ajax, Boston Sci partner to develop new heart failure treatment - BioWorld Online
Boston Scientific Stock: Is BSX Outperforming the Healthcare Sector? - Nasdaq
Insider Sell: Jeffrey Mirviss Sells 13,022 Shares of Boston Scie - GuruFocus.com
Is It Worth Investing in Boston Scientific (BSX) Based on Wall Street's Bullish Views? - Yahoo Finance
Boston Scientific Stock: Is BSX Outperforming The Healthcare Sector? - Barchart
Five things you need to know, and going for a chilly swim - The Business Journals
Boston Scientific buys Tivus system developer SoniVie in $540m deal - Medical Device Network
Boston Scientific Buying $600M Ultrasound System Developer - Law360
Boston Scientific to acquire Sonivie for up to $600M - BioWorld Online
Beyond The Numbers: 17 Analysts Discuss Boston Scientific Stock - Benzinga
Boston Scientific makes second acquisition for $360M upfront - The Business Journals
Boston Scientific to Purchase SoniVie Ltd. - MPO-mag
Boston Scientific to acquire renal denervation company SoniVie - Mass Device
Boston Scientific Announces Agreement To Acquire Sonivie Ltd -March 03, 2025 at 08:55 am EST - Marketscreener.com
Boston Scientific to acquire remaining 90% stake of SoniVie for $360M - TipRanks
Boston Scientific To Buy SoniVie For Upfront Payment Of Approx. $360 Mln - Nasdaq
Boston Scientific announces agreement to acquire SoniVie Ltd. - Quantisnow
The Zacks Analyst Blog The Goldman Sachs, The Progressive, Boston Scientific and Cooper-Standard - Zacks Investment Research
Boston Scientific Corporation entered into a definitive agreement to acquire remaining 90% stake in SoniVie Ltd for $540 million. - Marketscreener.com
Cavalier Investments LLC Raises Stock Holdings in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Bank of New York Mellon Corp Has $1.11 Billion Stock Holdings in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Top Stock Reports for Goldman Sachs, Progressive & Boston Scientific - Yahoo Finance
Boston Scientific Stock Price | BSX Stock Quote, News, and History - Markets Insider
Insider Selling: Boston Scientific Co. (NYSE:BSX) EVP Sells 4,675 Shares of Stock - MarketBeat
Consilium Wealth Advisory LLC Raises Holdings in Boston Scientific Co. (NYSE:BSX) - MarketBeat
April 11th Options Now Available For Boston Scientific (BSX) - Nasdaq
Boston Scientific Corporation (BSX): Among Stocks to Invest In from Israel Englander’s Portfolio - Insider Monkey
Boston Scientific Co. (NYSE:BSX) Shares Acquired by Alecta Tjanstepension Omsesidigt - MarketBeat
New York Life Investment Management LLC Raises Holdings in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Fisher Funds Management LTD Buys New Holdings in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific Announces Completion Of EUR1.5 Billion Offering Of Senior Notes - Marketscreener.com
Boston Scientific announces completion of €1.5 billion offering of senior notes - Quantisnow
Catheter Market Global Report and Company Analysis 2025-2033 Featuring Abbott Laboratories, BD and Co, Boston Scientific, Teleflex, Medtronic, Johnson & Johnson, Edwards Lifesciences, Stryker - Yahoo Finance
Boston Scientific's SWOT analysis: innovative medtech stock poised for growth - Investing.com
$1000 Invested In Boston Scientific 10 Years Ago Would Be Worth This Much Today - Benzinga
Boston Scientific Recalls Accolade Pacemaker Devices - The Rochester Sentinel
Boston Scientific reports first cases with next-gen Faraflex catheter - Mass Device
Boston Scientific director Zane Ellen M sells $1.42 million in stock By Investing.com - Investing.com South Africa
StockNews.com Downgrades Boston Scientific (NYSE:BSX) to Hold - MarketBeat
Boston Scientific Corp Stock (BSX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.40%
0.18%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):